SCI-Group
About[edit]
SCI-Group AS is a Norwegian deep technology company dedicated to transforming the global cryopreservation industry. Founded in 2005, the company has developed a patented cryopreservation technology.
Technology[edit]
CryoEmbla[edit]
CryoEmbla is SCI-Group's patented core technology enabling:
- Cryopreservation of living cells entirely without cytotoxic chemical cryoprotectants
- Significantly reduced use of cryoprotectants compared to conventional methods
- Safe, rapid, and efficient freezing of living cells
- Simplified handling and workflow
- Cryopreservation without DMSO or with strongly reduced DMSO
Conventional cryopreservation relies heavily on DMSO (dimethyl sulfoxide), which is cytotoxic and requires careful handling. CryoEmbla addresses this fundamental limitation.
Applications[edit]
- Cell therapy manufacturing
- Biobanking
- Advanced life sciences research
- Broader clinical and industrial use of living cells
Strategy[edit]
SCI-Group works closely with leading research institutions, industry partners, and investors to accelerate adoption of next-generation cryopreservation.
Vision[edit]
To set a new global standard for safe, efficient, and reproducible cryopreservation — unlocking value for medicine, science, and society.